Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Giosafat Spitaleri1, MD; Elisabetta Moscarella1, MD; Salvatore Brugaletta1*, MD, PhD; Alberto Pernigotti1, MD; Luis Ortega-Paz1, MD; Josep Gomez-Lara2, MD, PhD; Angel Cequier2, MD; Andrés Iñiguez3, MD; Antonio Serra4, MD; Pilar Jiménez-Quevedo5, MD; Vicente Mainar6, MD; Gianluca Campo7, MD; Maurizio Tespili8, MD; Peter den Heijer9, MD; Armando Bethencourt10, MD; Nicolás Vazquez11, MD; Marco Valgimigli12, MD, PhD; Patrick W. Serruys13, MD, PhD; Manel Sabaté

1. University Hospital Clínic, Cardiovascular Clinic Institute, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; 2. Department of Cardiology, University Hospital of Bellvitge, Barcelona, Spain; 3. Department of Cardiol

Aims: The aim of this substudy was to determine the five-year correlates of non-TV-related adverse events (AE) in STEMI patients included in the EXAMINATION trial.

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bare metal stentclinical researchmultiple vessel diseasest-elevation myocardial infarction (stemi)

STEMIStents and scaffolds

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy